Company: MBIO
Filing Date: 2025-12-03
Form Type: DEF 14A
Source: 0001104659-25-118122
Chunk: 6

Company: MUSTANG BIO, INC.
Filing Date: 2025-12-03
Form: DEF 14A
Chunk 6
---
 card or, if applicable, the telephone voting instructions that may be described on the voting instruction card sent to you by your broker or nominee. By Mail -You may authorize your proxy by signing your proxy card and mailing it in the enclosed, postage-prepaid and addressed envelope. For shares you hold in street name, you may sign the voting instruction card included by your broker or nominee and mail it in the envelope provided.

| Q: | What if I have technical difficulties or trouble accessing the virtual Annual Meeting? |

| A. | We will have technicians ready to assist you with any technical difficulties you may have accessing the virtual Annual Meeting.  If you encounter any difficulties accessing the virtual Annual Meeting during the check-in or meeting time, please call the technical support number located on the meeting page. |

| Q: | What is a proxy? |

| A. | A proxy is a person you appoint to vote your shares on your behalf.  If you are unable to attend the Annual Meeting, our board of directors is seeking your appointment of a proxy so that your shares may be voted.  If you vote by proxy, you will be designating Manuel Litchman, M.D. and Peter Carney our President, Chief Executive Officer and Interim Chief Financial Officer and Corporate Controller, respectively, as your proxies.  In such event, Dr. Litchman and Mr. Carney may act on your behalf and have the authority to appoint substitutes to act as your proxy. |

2

| Q: | How will my shares be voted if I vote by proxy? |

| A. | Your proxy will be voted according to the instructions you provide.  If you complete and submit your proxy but do not otherwise provide instructions on how to vote your shares, your shares will be voted (i) “FOR” the individuals nominated to serve as members of our board of directors, (ii) “FOR” the ratification of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2025, (iii) “FOR” the amendment to the Company’s 2019 Employee Stock Purchase Plan to increase the number of shares issuable by 250,000 shares and increase the number of shares subject to a Purchase Right thereunder to 10,000, and (iv) “FOR” the amendment to the Company’s 2016 Incentive Plan to increase the number of shares issuable by 2,500,000 shares. Presently, our board of directors does not know of